Acute Leukemia - Multidrug Resistance Studies
CALGB 9760: Multidrug Resistance Studies in Acute Leukemia
Protocol ID
02-214
Protocol Description
This study will investigate whether some leukemia cells are resistant or become resistant to chemotherapy drugs that are used to treat leukemia. In addition, we hope to learn whether attempting to make leukemia cells more sensitive to chemotherapy drugs is likely to improve response to treatment.
Eligibility Criteria
Patients with acute leukemia
Primary Investigator(s)
- Jonathan Kolitz, MD
Contact Information
Last Update
March 26, 2010How did I get to this page?
Persistent Navigation
- Home
- About Us
- Centers of Excellence
- Our Laboratories
- Research Topics
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
- Mental Health
- Neurosciences
- Radiation Medicine
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health
- Academics
- Resources for Investigators
- Upcoming Events